Netherlands· NL-acf7361531c8

Dolenio 1178 mg, filmomhulde tablet

A glucosamine product containing glucosaminesulfaat natriumchloride, registered in Netherlands by Blue Bio Pharmaceuticals Limited. The same ATC class is registered in 14 of our 19 countries.

ATC M01AX05

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about glucosaminesulfaat natriumchlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Glucosamine is registered in 14 of 19 countries.

Countries holding a registration under ATC M01AX05 (glucosamine), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
8 of them publish a price we can compare per daily dose

Search glucosamine products by name

Glucosamine · ATC M01AX05

14 / 19 countries

Belgiumprice
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
United Kingdom

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of glucosamine costs, country by country.

Normalised to the WHO defined daily dose (1.5 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Glucosamine · price per daily dose (1.5 g)

USD · FX 28 Sept 2026

ES Spain$0.23

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: GLUCOSAMINESULFAAT NATRIUMCHLORIDE
Manufacturer: Blue Bio Pharmaceuticals Limited
Country: Netherlands (NL)
ATC code: M01AX05
ATC class: Glucosamine
Defined daily dose: 1.5 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
103441

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

2 interactions on record for glucosamine.

Graded by severity as the source publishes them — 2 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check glucosamine against other medicines How interaction checks work

Glucosamine · interactions on record

2 records

2 moderate

Most severe, free to view

DicoumarolB01AA01moderate
WarfarinB01AA03moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Glucosamine in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All glucosamine products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

Cyprus · Donarthril
Czechia · Artaxin, Flexove
Germany · Glucosamin Doppelherzpharma
Spain · Acenam, Duartron
Finland · Glucosamin Orion
France · Flexea, Osaflexan
United Kingdom (Northern Ireland) · Glucosamine Medley Pharma, Yointy
Greece · Donarot, Energorot
Hungary · Cartilamin, Glukozamin Pharma Nord
Ireland · Arthrimel, Dona
Iceland · Glucomed
Norway · Glucosamin Orifarm, Samin
Poland · Flexove
Portugal · Biartril, Glucomed
Sweden · Artroxan, Glucomed
Slovakia · Glucomed

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/eafd126d-878b-41f2-aee9-1157f1c4860d
GET /v1/drugs/eafd126d-878b-41f2-aee9-1157f1c4860d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h103441_smpc.pdf",
  "strength": null,
  "atc_label": "Glucosamine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg103441",
  "excipients": [
    "HYPROMELLOSE (E 464)",
    "MACROGOL 4000",
    "MAGNESIUMSTEARAAT (E 470b)",
    "POLYSORBAAT 80 (E 433)",
    "POVIDON (E 1201)",
    "PROPYLEENGLYCOL (E 1520)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "GLUCOSAMINESULFAAT NATRIUMCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h103441.pdf",
  "authorised_at": "2009/02/25",
  "procedure_number": "DK/H/1580/001",
  "dispensing_status": "Uitsluitend apotheek of drogist",
  "registration_number": "103441",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about glucosamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console